Current and historical daily PE Ratio for Sartorius AG (
) from 1990 to Apr 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sartorius AG stock (XTER:SRT3) PE ratio as of Apr 29 2024 is 104.46.
More Details
Sartorius AG (XTER:SRT3) PE Ratio (TTM) Chart
Sartorius AG (XTER:SRT3) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Sartorius AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-29 | 133.6 | 2024-02-22 | 113.6 |
| 2024-04-26 | 133.6 | 2024-02-21 | 110.5 |
| 2024-04-25 | 129.8 | 2024-02-20 | 111.5 |
| 2024-04-24 | 134.8 | 2024-02-19 | 110.4 |
| 2024-04-23 | 134.2 | 2024-02-16 | 112.5 |
| 2024-04-22 | 125.7 | 2024-02-15 | 110.4 |
| 2024-04-19 | 125.0 | 2024-02-14 | 109.7 |
| 2024-04-18 | 128.3 | 2024-02-13 | 109.9 |
| 2024-04-17 | 151.7 | 2024-02-12 | 111.6 |
| 2024-04-16 | 155.6 | 2024-02-09 | 114.5 |
| 2024-04-15 | 157.6 | 2024-02-08 | 114.0 |
| 2024-04-12 | 154.1 | 2024-02-07 | 115.8 |
| 2024-04-11 | 159.0 | 2024-02-06 | 113.0 |
| 2024-04-10 | 156.5 | 2024-02-05 | 111.1 |
| 2024-04-09 | 162.0 | 2024-02-02 | 110.3 |
| 2024-04-08 | 160.4 | 2024-02-01 | 112.8 |
| 2024-04-05 | 157.0 | 2024-01-31 | 113.5 |
| 2024-04-04 | 161.1 | 2024-01-30 | 111.7 |
| 2024-04-03 | 161.9 | 2024-01-29 | 108.6 |
| 2024-04-02 | 164.0 | 2024-01-26 | 110.5 |
| 2024-03-28 | 169.6 | 2024-01-25 | 100.5 |
| 2024-03-27 | 121.2 | 2024-01-24 | 99.9 |
| 2024-03-26 | 123.4 | 2024-01-23 | 99.0 |
| 2024-03-25 | 123.3 | 2024-01-22 | 99.1 |
| 2024-03-22 | 127.1 | 2024-01-19 | 98.6 |
| 2024-03-21 | 124.0 | 2024-01-18 | 99.0 |
| 2024-03-20 | 121.0 | 2024-01-17 | 98.0 |
| 2024-03-19 | 121.4 | 2024-01-16 | 101.0 |
| 2024-03-18 | 118.6 | 2024-01-12 | 105.0 |
| 2024-03-15 | 120.6 | 2024-01-11 | 104.9 |
| 2024-03-14 | 121.5 | 2024-01-10 | 105.0 |
| 2024-03-13 | 119.9 | 2024-01-09 | 107.8 |
| 2024-03-12 | 120.0 | 2024-01-08 | 105.0 |
| 2024-03-11 | 119.4 | 2024-01-05 | 105.3 |
| 2024-03-08 | 121.9 | 2024-01-04 | 106.8 |
| 2024-03-07 | 122.5 | 2024-01-03 | 110.3 |
| 2024-03-06 | 118.2 | 2024-01-02 | 115.0 |
| 2024-03-05 | 116.0 | 2023-12-29 | 111.0 |
| 2024-03-04 | 115.6 | 2023-12-28 | 111.5 |
| 2024-03-01 | 117.1 | 2023-12-27 | 65.1 |
| 2024-02-29 | 116.5 | 2023-12-22 | 65.2 |
| 2024-02-28 | 115.0 | 2023-12-21 | 65.7 |
| 2024-02-27 | 113.8 | 2023-12-20 | 67.3 |
| 2024-02-26 | 112.3 | 2023-12-19 | 67.8 |
| 2024-02-23 | 113.6 | 2023-12-18 | 65.3 |
Sartorius AG (XTER:SRT3) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sartorius AG
ISIN : DE0007165631
Share Class Description:
XTER:SRT3: Vorz-Inhaber-Akt ohne StimmrechtCompare
Compare
Traded in other countries / regions
SRT3.Germany0NIR.UKSOAGY.USA1SRT3.ItalySRT3.MexicoSRT3.Austria IPO Date
1990-07-10Description
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers